- Home
- MAPS vs AVTX Comparison
MAPS vs AVTX Comparison
Compare MAPS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- AVTX
- Stock Information
- Founded
- MAPS 2008
- AVTX 2011
- Country
- MAPS United States
- AVTX United States
- Employees
- MAPS N/A
- AVTX N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MAPS Technology
- AVTX Health Care
- Exchange
- MAPS Nasdaq
- AVTX Nasdaq
- Market Cap
- MAPS 84.2M
- AVTX 90.9M
- IPO Year
- MAPS N/A
- AVTX 2015
- Fundamental
- Price
- MAPS $0.99
- AVTX $12.58
- Analyst Decision
- MAPS Buy
- AVTX Buy
- Analyst Count
- MAPS 2
- AVTX 2
- Target Price
- MAPS $2.61
- AVTX $35.00
- AVG Volume (30 Days)
- MAPS 938.6K
- AVTX 64.4K
- Earning Date
- MAPS 11-12-2024
- AVTX 11-07-2024
- Dividend Yield
- MAPS N/A
- AVTX N/A
- EPS Growth
- MAPS N/A
- AVTX N/A
- EPS
- MAPS N/A
- AVTX N/A
- Revenue
- MAPS $183,311,000.00
- AVTX $820,000.00
- Revenue This Year
- MAPS N/A
- AVTX N/A
- Revenue Next Year
- MAPS $9.09
- AVTX N/A
- P/E Ratio
- MAPS N/A
- AVTX N/A
- Revenue Growth
- MAPS N/A
- AVTX N/A
- 52 Week Low
- MAPS $0.70
- AVTX $3.95
- 52 Week High
- MAPS $1.47
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- MAPS 67.26
- AVTX 52.17
- Support Level
- MAPS $0.71
- AVTX $12.00
- Resistance Level
- MAPS $1.15
- AVTX $13.59
- Average True Range (ATR)
- MAPS 0.08
- AVTX 0.96
- MACD
- MAPS 0.03
- AVTX -0.15
- Stochastic Oscillator
- MAPS 64.82
- AVTX 33.52
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).